Key points r GABA transporter (GAT) blockade recruits extrasynaptic GABA A receptors (GABA A Rs) and amplifies constitutive presynaptic GABA B R activity.
Introduction
Paraventricular nucleus of the hypothalamus (PVN) corticotropin-releasing hormone (CRH) neurons integrate synaptic information from multiple brain regions and launch the endocrine stress response. GABA synapses account for over half of all synaptic contacts onto CRH neurons in the PVN (Miklós & Kovács, 2012) , and tightly regulate corticosteroid (CORT) levels in response to stress (Cole & Sawchenko, 2002; Hewitt et al. 2009 ); yet, our understanding of the processes that control signalling at GABA synapses on PVN CRH neurons is surprisingly limited. Consistent with findings in other brain regions, the binding of GABA to synaptic GABA A receptors (GABA A Rs) on PVN CRH neurons causes a rapid and phasic inhibition (I Phasic ); these neurons also show a slow and persistent tonic inhibition (I Tonic ) in response to GABA binding to extrasynaptic GABA A Rs (Sarkar et al. 2011) . These distinct forms of inhibition will have very different consequences on neuronal output, yet we know relatively little about what controls the balance between I Phasic and I Tonic .
Since the high-affinity GABA A Rs responsible for I Tonic reside in extrasynaptic regions (Rossi & Hamann, 1998; Lee et al. 2014) , mechanisms that control both the concentration of GABA and its access to extra-and perisynaptic regions will impact the balance between I Tonic and I Phasic . GABA transporters (GATs) in astrocytes and neurons play a key role in constraining I Tonic in other cell populations in PVN (Park et al. 2006 (Park et al. , 2009 Pandit et al. 2015) . Additionally, presynaptic GABA B Rs, which decrease release probability (P r ) of GABA, are also present within the PVN (Liu et al. 2006; Gao et al. 2017) . The recruitment of GABA B Rs, which are likely sensitive to GABA uptake, should decrease I Phasic , but whether GABA B Rs also impact I Tonic indirectly in PVN CRH neurons is not known.
PVN CRH neurons initiate an endocrine cascade that increases circulating CORT. CORT has been shown to directly (Senst et al. 2016) and indirectly (Di et al. 2003; Wamsteeker et al. 2010 ) decrease excitability of PVN CRH neurons, but the effects of CORT on GABA transmission are not clear. Reports indicate that CORT either decreases (Verkuyl et al. 2004 (Verkuyl et al. , 2005 or has no effect (Wamsteeker Cusulin et al. 2013 ) on synaptic I Phasic . Furthermore neurosteroids, metabolites of CORT precursors also produced during hypothalamic-pituitary-adrenal (HPA) activation (Reddy & Rogawski, 2002; Gunn et al. 2011) , bind extrasynaptic GABA A Rs in PVN CRH neurons, enhancing I Tonic (Lee et al. 2016) . However, there has been no direct test of CORT actions on extrasynaptic I Tonic .
Here we tested the hypothesis that GABA uptake gates presynaptic GABA B R and extrasynaptic GABA A R activity in PVN CRH neurons. Furthermore, we test whether CORT incubation, precluding the action of neurosteroids, can alter the balance between tonic and phasic inhibition in PVN CRH neurons. Our findings indicate that GATs and presynaptic GABA B Rs act cooperatively to limit I Tonic and I Phasic . CORT increases I Tonic without impacting I Phasic ; this effect is masked by the efficient clearance of GABA from the extrasynaptic space.
Methods

Ethical approval
All protocols received approval from the University of Calgary Animal Care and Use Committee AC17-0040 in accordance with the guidelines of the Canadian Council on Animal Care, and the Journal of Physiology's guideline on animal ethics.
Animals
Ai14 mice (B6.Cg-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze ) (Madisen et al. 2010) and Crh-IRES-Cre (B6(Cg)-Crh tm1(cre)Zjh ) (Taniguchi et al. 2011) were backcrossed to C57Bl/6J following their arrival from Jackson Laboratories (Bar Harbor, ME, USA; stock number 007914 and 012704, respectively), and maintained as separate homozygous colonies. Genetic mutants were screened for using PCR procedures provided by the supplier. The following primers were used to identify Ai14 mutants: 5 -GGCAT TAAAGCAGCGTATCC-3 and 5 -CTGTTCCTGTACGG CATGG-3 (196 base pair band). Crh-IRES-Cre mutants were identified using: 5 -CTTACACATTTCGTCCTAG CC-3 and 5 -CAATGTATCTTATCATGTCTGGATCC-3 (468 base pair band). Mice were housed on a 12:12 h light/dark cycle with ad libitum access to food and water. Breeding pairs with one homozygous male were crossed with genetically counterbalanced pairs of homozygous females from either Crh-IRES-Cre or Ai14 strains. The resultant heterozygous Crh-IRES-Cre;Ai14 (CRH-tdTomato) offspring were used in subsequent experiments.
Slice preparation and electrophysiology
Male and female CRH-tdTomato mice aged postnatal day (p)21-35 were anaesthetized with isofluorane prior to decapitation. The brains were rapidly removed and transferred into slicing solution (0°C, saturated with 95% O 2 /5%CO 2 ), containing (in mM) 87 NaCl, 2.5 KCl, 25 NaHCO 3 , 0.5 CaCl 2 , 7 MgCl 2 , 1.25 NaH 2 PO 4 , 25 D-glucose and 75 sucrose. Brains were allowed to cool before being coronally sectioned to 250 μm slices on a vibratome (Leica VT1200S, Wetzlar, Germany). Slices were transferred to ACSF (30°C, saturated with 95% O 2 /5%CO 2 ) containing (in mM) 126 NaCl, 2.5 KCl, 26 NaHCO 3 , 2 CaCl 2 , 2 MgCl 2 , 1.25 NaH 2 PO 4 and 10 Dglucose. Slices were given a 1-h recovery period before being removed from the incubation chamber and allowed to return to room temperature. Slices treated with CORT were transferred from ACSF to a small incubating chamber containing 100 nM CORT dissolved in ACSF for 1 h prior to recording. Following recovery, slices were transferred to a recording chamber superfused with ACSF (1 ml min −1 , 30-32°C, saturated with 95% O 2 /5%CO 2 ) and cells were visualized with an upright microscope (BX51WI, Olympus, Tokyo, Japan) fitted with DIC optics, metal halide fluorescence lamp, (X-Cite Series 120, EXFO, Quebec City, QC, Canada) and digital camera (OLY-150, Olympus). In the indicated experiments, the following compounds were added via syringe pump (R-99, Razel, St. Albans, VT, USA): 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 μM, Tocris, Bristol, UK), picrotoxin (PTX, 100 μM, Sigma, St Louis, [CGP 55845 (CGP) , 2 μM, Tocris] and 5-aminomethyl-3-hydroxyisoxazole (muscimol, 1-300 μM, Tocris) PVN CRH neurons were identified based on location (Biag et al. 2012 ) and tdTomato fluorescence. Borosilicate glass micropipettes (BF150-86-10, Sutter Instruments, Novato, CA, USA) pulled on a horizontal pipette puller (3-5 M ; P-97, Sutter Instruments) and filled with a solution containing (in mM): 140 KCl, 8 sodium gluconate, 2.5 K 2 EGTA, 10 Hepes, 2 MgCl 2 , 4 K 2 ATP and 0.3 Na 3 GTP were used for whole-cell patch clamp recordings. CRH neurons were voltage-clamped at −70 mV while under constant perfusion with DNQX. Pairs of eIPSCs were elicited by delivering current into the neuropil (100-150 μs, 10-50 V; 50 ms interstimulus interval, 0.2 Hz; S88 stimulator, Grass, West Warwick, RI, USA) with a monopolar ACSF-filled micropipette (4-6 M ) located 40-60 μm medioventral to the PVN CRH neuron. Access resistance was monitored throughout the experiment, and cells were excluded from analysis if it exceeded 20 M or a 15% change.
Data analysis and statistics
Signals were amplified (Multiclamp 700B, Molecular Devices, Sunnyvale, CA, USA), digitized at 10 kHz (Digidata 1440A, Molecular Devices), low-pass filtered at 1 kHz and recorded (pClamp 10.4, Molecular Devices) for offline analysis. All data are reported as mean ± SEM. eIPSC amplitudes were measured by subtracting the peak synaptic current from the baseline current. sIPSC amplitude and frequency, with evoked currents and electrical stimulation artefacts removed, were detected using automated search parameters and confirmed by eye (MiniAnalysis, Synaptosoft, Decatur, GA, USA). Data were normalized and expressed as a percentage of the baseline values (−5 to 0 min prior to drug application) in each cell. Paired pulse ratios were determined by averaging 2 min of the peak amplitude of eIPSCs elicited 50 ms apart and then taking the ratio of the second response over the first to minimize spurious measurements (Kim & Alger, 2001) .
Histograms measuring the holding current were generated by measuring 1 s samples collected every 5 s from the raw traces. During the 1 s epochs, sIPSC events were excluded by thresholding data collected at a point below the negative limit of the holding current, but bins have a skewed distribution towards more negative values. To ensure sIPSC events were not included in the analysis we fitted Gaussian distributions to the histograms, and used the peak values for comparisons as described previously (Glykys & Mody, 2006) .
Statistical comparisons were made using GraphPad Prism 6 (La Jolla, CA, USA). One-tailed Student's t tests were used to test for significant differences between naïve and CORT-treated effects of Nip A. Comparisons of drug-induced changes to their respective baselines were statistically tested by one-way ANOVA with a Dunnet correction for multiple comparisons.
Dose-response curves to muscimol puffs were generated by measuring the peak current elicited by muscimol. Muscimol (20 ms, 1-300 μM, 20 psi) was focally applied via picospritzer II (General Valve Corporation, Fairfield, NJ, USA) through a pipette (2-4 M ) containing muscimol dissolved in ACSF. The puff pipette was positioned 25 μm from the patched PVN CRH neuron. Slices from the same animal were interleaved between naïve and CORT treatment. Data were fitted with a non-linear equation to examine EC 50 , and tested with a two-way ANOVA for significance between-treatment groups. The significance of comparisons within groups was denoted with * P < 0.05, * * P < 0.01 and * * * P < 0.001, while the significance of comparisons of Nip A-induced I Tonic between groups was denoted with # P < 0.05.
Results
First, we examined the effects of GAT blockade on phasic GABA currents in PVN CRH neurons (Fig. 1A) . To characterize the role of individual GATs in regulating phasic GABA signalling, we examined spontaneous IPSC (sIPSC) frequency and amplitude following application of the specific GAT1 (NNC711, 10 μM) and GAT3 (SNAP 5114, 50 μM) antagonists. The specific GAT1 antagonist did not alter sIPSC frequency (Baseline: 1.4 ± 0.2 Hz, n = 6, NNC711: 1.2 ± 0.2 Hz, P = 0.18 vs. baseline, n = 6) or amplitude (Baseline: 70.3 ± 6.0 pA, n = 6, NNC711: 73.1 ± 7.6 pA, P = 0.56 vs. baseline, n = 6). Similarly, blocking GAT3 alone, also did not alter sIPSC frequency (Baseline: 2.4 ± 0.7 Hz, n = 7, SNAP 5114: 2.8 ± 0.7 Hz, P = 0.22 vs. baseline, n = 7) or amplitude (Baseline: 84.8 ± 19.7 pA, n = 7, SNAP 5114: 95.4 ± 20.1 pA, P = 0.61 vs. baseline, n = 7). This is consistent with previous reports suggesting that GATs operate synergistically, and that spillover may be evident only upon block of both GAT1 and GAT3 (Kirmse et al. 2009 ). Therefore, we examined the effects of the non-specific GAT antagonist, Nip A ( reduced the mean evoked IPSC (eIPSC) amplitude (Baseline: 104.4 ± 9.4%, n = 6, Nip A: 43.0 ± 6.1%, P < 0.001 vs. baseline, n = 6, Fig. 1C ). Bic (10 μM) application blocked eIPSCs completely (3.1 ± 0.4%, P < 0.001 vs. baseline, n = 6, Fig. 1C ). The paired pulse ratio (PPR) was not significantly altered by the addition of Nip A (Baseline: 0.68 ± 0.06, n = 6, Nip A: 0.84 ± 0.10, P = 0.21 vs. baseline, n = 6, Fig. 1D and E) . Blocking GAT1 and GAT3 with Nip A significantly reduced the frequency of sIPSCs (Baseline: 90.2 ± 10.0%, n = 6, Nip A: 27.8 ± 7.3%, P < 0.001, n = 6, Fig. 1G ), but did not alter sIPSC amplitude (Baseline: 99.1 ± 4.8%, n = 6, Nip A: 105.9 ± 10.7%, P = 0.82 vs. baseline, n = 6) (Fig. 1H) . Bic application blocked sIPSC events entirely (frequency 0.0 ± 0.0%, P < 0.001 vs. baseline, n = 6; amplitude 0.0 ± 0.0%, P < 0.001 vs. baseline, n = 6). Blocking GABA reuptake allows GABA to spill over into the extrasynaptic space, where it can bind to extrasynaptic GABA A Rs and GABA B Rs. GABA B Rs have been described in the PVN (Margeta Mitrovic et al. 1999) in both the pre-and the postsynaptic membranes (Gao et al. 2017 ). We applied the GABA B R antagonist CGP (2 μM) to test whether constitutive activity of GABA B Rs modulates I Phasic in PVN CRH neurons (Fig. 2) . Application of CGP increased eIPSC amplitude (Baseline: 104.5 ± 7.1%, n = 8, CGP: 190.4 ± 22.9%, P = 0.049 vs. baseline, n = 8, Fig. 2A  and 3A) . PPR was significantly reduced by CGP (Baseline: 1.05 ± 0.06, n = 8 vs. CGP: 0.85 ± 0.05, P = 0.008, n = 8, Fig. 2B ). The basal properties of sIPSC frequency (Naïve: 1.73 ± 0.47 Hz, n = 6, CGP: 1.22 ± 0.33 Hz, n = 8, P = 0.44) and amplitude (Naïve: 120.9 ± 33.7 pA, n = 6, CGP: 153.1 ± 13.8 pA, n = 8, P = 0.50) were not different between naïve and CGP-treated groups. A and B, eIPSC amplitude (overall ANOVA F 3,7 = 12.76, P = 0.004) and sIPSC frequency (overall ANOVA F 3,7 = 12.22, P < 0.001) increase following CGP application. CGP prevents a Nip A-induced reduction of eIPSC amplitude and sIPSC frequency. C, sIPSC amplitude (overall ANOVA F 3,7 = 134.8, P < 0.001) is unaltered by CGP application, but decreases in Nip A. Post-hoc analysis values * P < 0.05, * * P < 0.01. Data shown as mean ± SEM.
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However, compared to baseline within the experimental group, CGP application increased sIPSC frequency (Baseline: 97.1 ± 3.2%, n = 8, CGP: 191.5 ± 22.5%, P = 0.046 vs. baseline, n = 8, Fig. 2C and 3B ), but did not affect sIPSC amplitude (Baseline: 101.3 ± 1.7%, n = 8, CGP: 106.7 ± 8.0%, P < 0.88 vs. baseline, n = 8; Fig. 3C ). Subsequent application of Nip A had no effect on eIPSC amplitude (Nip A: 178.9 ± 46.6% of baseline, P = 0.99 vs. CGP, n = 8, Fig. 3A) , PPR (Nip A: 0.92 ± 0.05, P = 0.48 vs. CGP, n = 8) or sIPSC frequency (Nip A: 151.9 ± 47.9%, P = 0.64 vs. baseline, n = 8, Fig. 3B ).
There was a significant reduction in sIPSC amplitude (Nip A: 80.2 ± 4.8%, P = 0.006 vs. CGP, n = 8, Fig. 3C ). These data show that GABA B Rs are constitutively active in hypothalamic slices and suppress GABA release at presynaptic terminals. Furthermore, the reduction of I Phasic following inhibition of GATs is entirely mediated by activation of presynaptic GABA B Rs. Next, we examined the role of GATs in regulating I Tonic in PVN CRH neurons. The non-competitive GABA A R antagonist, PTX (100 μM), had no effect on holding current in cells voltage clamped at −70 mV (Baseline: 0.9 ± 12.7 pA, n = 6, PTX: 3.4 ± 12.2 pA, P = 0.56 vs. baseline, n = 6, two-tailed t test, Fig. 4A and B) . Inhibition of either GAT1 (Baseline: 9.8 ± 9.3 pA, n = 7, NNC711: 6.0 ± 8.0 pA, P = 0.52 vs. baseline, n = 7) or GAT3 (Baseline: 6.5 ± 6.9 pA, n = 6 vs. SNAP 5114: −11.3 ± 5.5 pA, P = 0.60 vs. baseline, n = 6) alone had no effect on I Tonic . Inhibiting both GAT1 and GAT3 with Nip A caused a significant shift in the holding current (Baseline: 2.2 ± 3.3 pA, n = 6, Nip A: −46.7 ± 10.2 pA; P < 0.001 vs. baseline, n = 6, Fig. 4C and D) . I Tonic was blocked by subsequent application of the competitive GABA A R antagonist, Bic (−9.7 ± 7.0 pA; P = 0.43 vs. baseline, P = 0.006 vs. Nip A, n = 6). These findings indicate that in basal conditions, GATs efficiently remove GABA from the cleft thereby preventing activation of extrasynaptic GABA A Rs on PVN CRH neurons. Because inhibition of GABA uptake activates presynaptic GABA B Rs and decreases release probability, we asked whether this may limit I Tonic . CGP by itself had no effect on the holding current (Baseline: 2.1 ± 1.1 pA, n = 8, CGP: 10.2 ± 2.6 pA, P = 0.17 vs. baseline, n = 8 Fig. 4E and F) . In the presence of CGP, Nip A induced a significantly larger I Tonic (CGP + Nip A: −82.4 ± 15.8. P = 0.005 vs. CGP, n = 8, Fig. 4E and  F) , than that observed in Nip A alone (F 6,43 = 17.97, P = 0.004). The Nip A-mediated change in holding current was completely blocked by PTX (PTX: −8.2 ± 4.7 pA, vs. CGP + Nip A, n = 8, P < 0.001). These data show that GATs and GABA B Rs work cooperatively to limit I Tonic in CRH neurons.
Previous reports have implicated a role for neurosteroids in the regulation of I Tonic in the PVN (Sarkar et al. 2011; Gunn et al. 2013) . PVN CRH neurons are also a principal target for circulating corticosterone, and although CORT does not appear to have effects on I Phasic (Wamsteeker Cusulin et al. 2013) , its effects on I Tonic have not been investigated. First, we confirmed that incubating hypothalamic slices with CORT (100 nM, 1 h) was without effect on Nip A-induced changes in I Phasic (Fig. 5A) . Nip A depressed eIPSCs (Baseline: 100.6 ± 6.5%, n = 7, Nip A: 27.1 ± 6.3%, P < 0.001 vs. baseline, n = 7, Fig. 5B and C). This was not significantly different from naïve (P = 0.099, Student's t test). PPR at baseline (0.79 ± 0.05, n = 7) was not different from that in naïve PVN CRH neurons (P = 0.22, two-tailed t test); Nip A application significantly increased PPR (1.10 ± 0.12, P = 0.027 vs. baseline, n = 7, Fig. 5D and E) . Basal properties of sIPSC frequency (Naïve: 1.73 ± 0.47 Hz, n = 6, CORT:
1.09 ± 0.24 Hz, n = 7, P = 0.44) and amplitude (Naïve: 120.9 ± 33.7 pA, n = 6, CORT: 121.2 ± 9.3 pA, n = 7, P = 0.99) were unaltered between naïve and CORT-treated groups. Within the CORT-treated group, Nip A reduced sIPSC frequency (Baseline: 104.7 ± 10.1%, n = 7, Nip A: 33.6 ± 5.3%, P < 0.001 vs. baseline, n = 7) and amplitude (Baseline: 95.9 ± 4.2%, n = 7, Nip A: 71.8 ± 8.4%, P = 0.049 vs. baseline, n = 7).
Next, we examined the effects of CORT incubation on I Tonic . PTX had no significant effect on baseline holding current (Baseline: 3.9 ± 5.8 pA, n = 6, PTX: 6.3 ± 4.6 pA, n = 6, P = 0.39, two-tailed t test, Fig. 6A) . Application of Nip A application unmasked I Tonic (Baseline: −1.9 ± 0.9 pA, n = 7, Nip A: −105.1 ± 24.0 pA, P < 0.001 vs. baseline, n = 7, Fig. 6B ). This was significantly larger than the I Tonic observed in naïve slices (F 5,33 = 11.87, P = 0.002). Bic blocked I Tonic (Bic: −26.1 ± 6.2 pA, P = 0.43 vs. baseline, n = 7). These observations are consistent with an increase in extrasynaptic GABA A R activation following CORT. Given that Nip A affected I Phasic in naïve and CORT-treated slices similarly, the observed increase in I Tonic unmasked by CORT is probably not due to an increase in P r at GABA synapses. The absence the postsynaptic neuron in naïve or CORT-treated slices (Fig. 6C) . We analysed the peak current elicited by muscimol from interleaved naïve and CORT-treated slices from the same animals. CRH neurons from naïve and CORT-treated slices exhibited dose-dependent I Tonic in response to increasing concentrations of muscimol (F 5,60 = 71.12, P < 0.001, two-way ANOVA, Fig. 6C ).
The dose-response relationships between naïve and CORT cells was significantly different (F 1,60 = 11.13, P = 0.0015). The LogEC 50 between naïve and CORT treatment did not differ (F 1,70 = 0.0070, P = 0.93), but there was a significantly larger current in CORT-treated slices in response to the highest concentration of muscimol (P = 0.027 vs. naïve). These data indicate that CORT incubation does not affect the potency of muscimol but it does increase efficacy. This indicates that the increase in I Tonic following CORT is due to an increase in the number or conductance of extrasynaptic GABA A Rs.
Discussion
In this study, we demonstrate that GABA in the extrasynaptic space acts at both GABA B Rs and extrasynaptic GABA A Rs on PVN CRH neurons. Incubation of hypothalamic slices with physiological concentrations of CORT increased I Tonic but not I Phasic in these cells. In all cases, I Tonic was unmasked only when neuronal and glial GABA transporters were blocked. In addition to preventing GABA spillover and activation of extrasynaptic GABA A Rs, these GATs also limit, but do not completely prevent, the activation of presynaptic GABA B Rs. Collectively, these observations demonstrate that GATs and GABA B Rs act cooperatively to create conditions that favour I Phasic , not I Tonic (Fig. 7) . Previous reports have shown that chronically elevated CORT alters the relative composition of GABA A R subunits (Orchinik et al. 1995; . Similarly, stress increases I Tonic , but this is thought to be mediated primarily through the actions of neurosteroids, notably the deoxycorticosterone (DOC) metabolite, tetrahydrodeoxycorticosterone (THDOC) acting as a positive allosteric modulator on δ-subunit containing GABA A Rs (Maguire & Mody, 2007; Gunn et al. 2011; Sarkar et al. 2011) . While the conversion of DOC to CORT is carried out by 11β-hydroxylase, which is present in the hypothalamus (Ye et al. 2008) , and THDOC increases in the plasma after acute stress (Purdy et al. 1991) , THDOC is not derived from CORT, but rather its precursor, DOC (Agís-Balboa et al. 2006) . Therefore, it is unlikely that CORT is metabolized into THDOC, suggesting that physiological levels (100 nM) of CORT increase I Tonic in PVN CRH neurons. The observation that there is an increased sensitivity to the exogenous GABA A ligand, muscimol, following CORT is consistent with an increase in either the number or the conductance of extrasynaptic GABA A receptors. The mechanism by which CORT modulates I Tonic is unknown, but a recent study found a neurosteroid binding site within a conserved transmembrane region of α5 GABA A Rs (Miller et al. 2017) . Furthermore, the 3α and 5α reductases responsible for production of neurosteroids also convert CORT to 3α, 5α tetrahydrocorticosterone (3α, 5α THB) (Traish et al. 2015) , leading to the possibility of 3α, 5α THB binding to this neurosteroid site to modulate I Tonic .
The presence of an auto-regulatory role for presynaptic GABA B Rs in the rat hypothalamus is controversial, and has previously been shown in an undefined population of rat parvocellular neurosecretory cells (Liu et al. 2006) . A recent study examining PVN CRH neurons in rats, however, was unable to replicate this, instead reporting GABA B R-mediated suppression only after a chronic unpredictable mild stress paradigm (Gao et al. 2017) . One explanation for the discrepancy may be attributed to the difference in the age of animals used in each study. Here, we used slices from mice ranging in age From p21 to p35, similar to Liu et al. (2006) (3-4 weeks); Gao et al. (2017) used older rats (7-10 weeks) and the absence of GABA B effects may be due to the decrease in GABA B R expression in older rat hypothalamus (Bianchi et al. 2005) . By suppressing GABA release under basal conditions, GABA B Rs function as an effective high-pass filter that allows GABA synapses to facilitate more readily under conditions that favour higher activity rates in GABA afferents.
During unstressed conditions, strong GABAergic drive would activate GABA B Rs, thereby blunting the further release of GABA. Conversely, weak GABAergic drive would release presynaptic GABA terminals from . Extrasynaptic mechanisms regulate GABA signalling Schematic illustrating that constitutive activation of GABA B Rs restricts GABA release and that conditions promoting GABA spillover increase GABA B R activation and elicit tonic GABA A R signalling, which is enhanced following CORT incubation through an unknown mechanism.
GABA B R constraint, and instead promote GABA release. This bidirectional control over GABA release implicates autoinhibition by GABA B Rs as a mechanism to (1) set inhibitory tone onto PVN CRH neurons, and (2) prevent saturation of afferent GABA drive. The emergence of an extrasynaptic GABA A R tone when GATs are blocked indicates that under basal conditions, GATs proficiently limit access of GABA to extrasynaptic sites. The potentiated I Tonic in CORT-incubated slices (following GAT blockade) indicates that increased surface expression of extrasynaptic GABA A Rs following stress may be important for modifying GABA signalling in the PVN.
A growing body of evidence shows that extrasynaptic GABA A Rs and neurosteroids play an important role in determining network excitability (Stell et al. 2003; Glykys & Mody, 2006; Lee et al. 2014) . Therefore, this CORT-induced increase in surface expression of neurosteroid-sensitive extrasynaptic GABA A Rs represents a novel mechanism through which to examine CORT feedback-induced changes onto HPA excitability. Following acute stress, activity of PVN-projecting GABA neurons from some stress-associated regions is enhanced (Cullinan et al. 1995; 1996; Campeau & Watson, 1997) ; furthermore, GABA afferents onto PVN CRN neurons become excitatory due to a postsynaptic collapse in the chloride gradient (Hewitt & Bains, 2006; Sarkar et al. 2011) . Heightened activity in GABA afferents following stress could drive activation of GABA B Rs, reducing the probability of release and thereby limiting the excitatory action of GABA following stress. Increased GABA input paired with the enhanced I Tonic following stress could provide a larger shunting conductance, thereby reducing the input resistance of PVN CRH neurons and dampening the excitatory effect of GABA. Therefore, autoinhibition and stress-induced enhancement of extrasynaptic GABA A R tone represent two mechanisms by which to limit the excitatory role of GABA following stress.
Interestingly, the application of Nip A caused a reduction in the amplitude of sIPSC events in both CGP-treated and CORT-treated cells. Phosphorylation of synaptic GABA A Rs is known to alter receptor function (Jones & Westbrook, 1997; Kittler & Moss, 2003; Farrant & Nusser, 2005) , and kinases could be recruited by CORT incubation. Furthermore, the increase in extrasynaptic GABA A R expression following stress could be due to lateral diffusion of synaptic GABA A Rs to the extrasynaptic space (Luscher & Keller, 2004; de Luca et al. 2017) . Finally, blocking GATs and GABA B Rs both act to increase the concentration of GABA in the synaptic cleft, which may contribute to receptor desensitization (Bianchi et al. 2001; Farrant & Nusser, 2005) .
The data reported here show that the handling of extrasynaptic GABA in the PVN has multiple effects on the strength of GABA input onto PVN CRH neurons. By manipulating the degree of GABA spillover within J Physiol 596.10 the PVN, GATs bidirectionally alter the excitability of PVN CRH neurons: either decreasing excitability through extrasynaptic GABA A Rs (probably δ-containing GABA A Rs; Lee et al. 2014) , or increasing excitability through disinhibition via GABA B Rs reducing the release probability at GABA synapses.
